Concepedia

Ehsan Irajizad

EI

23

Publications

894

Citations

16

H-Index

2017

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Fred Hutch Cancer Center

Baylor College of Medicine

Dana-Farber Cancer Institute

Harvard University

Ehsan Irajizad is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cancer research, and pathology.

ORCID

Top concepts

Publications per year

2017–2023

23

Publications

23

Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection

Johannes F. Fahrmann, C. Max Schmidt, Xiangying Mao et al. · Gastroenterology · 2020 · 184 citations · Full text

, , +9

Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast Cancer

Johannes F. Fahrmann, Jody V. Vykoukal, Alia Fleury et al. · JNCI Journal of the National Cancer Institute · 2019 · 103 citations · Full text

Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment

Johannes F. Fahrmann, Tracey L. Marsh, Ehsan Irajizad et al. · Journal of Clinical Oncology · 2022 · 92 citations · Full text

Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer

Jody V. Vykoukal, Johannes F. Fahrmann, Justin R. Gregg et al. · Nature Communications · 2020 · 79 citations · Full text

Protein citrullination as a source of cancer neoantigens

Hiroyuki Katayama, Makoto Kobayashi, Ehsan Irajizad et al. · Journal for ImmunoTherapy of Cancer · 2021 · 41 citations · Full text

Rows per page

1–5 of 23